A Clinical trial on pathiri ver chooranam in the management of madhumega noi (Diabetes mellitus) among patients attending OPD and IPD of Government Siddha Medical College and Hospital,Palayamkottai

A Prospective, open labelled, single arm, non randomized, single centric, phase II, Clinical trail to determine the effectiveness of Pathiriver chooranam in the management of Madhumega Noi(Diabetes mellitus) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068174

Enrollment

Registered

2024-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Pathiri ver chooranam: DOSAGE: 1 to 2 gms (Twice a day orally) Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Even if patient is having any one among the three (WHO criteria 2019): a. FBS above 126 mg/dl and below 250mg/dl or b. PPBS above 200mg/dl and below 350mg /dl or c. HbA1c above 6.5 and below 10 2. Patients with symptoms of polyuria, polydipsia , polyphagia, asthenia, nocturia,obesity ( metabolic syndrome) , numbness, tingling sensation, mood changes and irritability, difficulty in concentration.

Exclusion criteria

Exclusion criteria: 1.Age below above 34 years and below 60 years 2.Type 1 diabetes mellitus 3.Gestational DM 4.Diabetes insipidus 5.Pregnancy 6.Lactating mother 7.Chronic kidney disease 8.Chronic lever disease 9.Ischemic heart diseases

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing symptoms of Diabetes mellitus and to determine the therapeutic efficacy of Pathiriver chooranamTimepoint: 3 months	—

Secondary

Measure	Time frame
1.To collect various siddha literatures and modern journals. 2.To evaluate Physio Chemical, Phyto Chemical, Bio Chemical analysis. 3.To study the anti-microbial activity for selected micro-organism 4.To evaluate Pharmacological activities 5.To evaluate safety profile for acute and sub-acute toxicity 6.To evaluate modern parametric changes in Madhumegam 7.To evaluate the cell line study of anti-diabetic activity 8.To evaluate siddha parameters and compare the changes in Madhumegam during trial period. Timepoint: 6 months	—

Measure

Time frame

1.To collect various siddha literatures and modern journals. 2.To evaluate Physio Chemical, Phyto Chemical, Bio Chemical analysis. 3.To study the anti-microbial activity for selected micro-organism 4.To evaluate Pharmacological activities 5.To evaluate safety profile for acute and sub-acute toxicity 6.To evaluate modern parametric changes in Madhumegam 7.To evaluate the cell line study of anti-diabetic activity 8.To evaluate siddha parameters and compare the changes in Madhumegam during trial period. Timepoint: 6 months

—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli Alias Mehala

Government Siddha Medical College And Hospital

drpsk_md@yahoo.in9944337757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026